Article Information
History
- February 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Erik N. Bergstrom1,2,3,
- Ammal Abbasi1,2,3,
- Marcos Díaz-Gay1,2,3,
- Loïck Galland4,5,6,7,
- Scott M. Lippman1,
- Sylvain Ladoire4,5,6,7 and
- Ludmil B. Alexandrov1,2,3,*
- 1Moores Cancer Center, UC San Diego, La Jolla, CA, 92037, USA
- 2Department of Cellular and Molecular Medicine, UC San Diego, La Jolla, CA, 92093, USA
- 3Department of Bioengineering, UC San Diego, La Jolla, CA, 92093, USA
- 4Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France
- 5Platform of Transfer in Biological Oncology, Centre Georges-François Leclerc, Dijon, France
- 6University of Burgundy-Franche Comté, France
- 7Centre de Recherche INSERM LNC-UMR1231, Dijon, France
- ↵*Correspondence should be addressed to L2alexandrov{at}health.ucsd.edu.
Posted February 26, 2023.
Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer
